Esophageal Doppler ultrasound-based cardiac output monitoring for real-time therapeutic management of hospitalized patients a review
The Centers for Medicare & Medicaid Services (CMS) requested that AHRQ commission an evidence report to inform CMS of the evidence regarding ultrasound-based monitoring of cardiac output (Doppler). This is currently listed as a Category II procedure (clinical reliability and efficacy not proven)...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Rockville, Maryland
Agency for Healthcare Research and Quality
January 16, 2007, 2007
|
| Series: | Technology assessment
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The Centers for Medicare & Medicaid Services (CMS) requested that AHRQ commission an evidence report to inform CMS of the evidence regarding ultrasound-based monitoring of cardiac output (Doppler). This is currently listed as a Category II procedure (clinical reliability and efficacy not proven), which is "considered experimental and should not be covered at this time". Accordingly, on May 9th 2006, AHRQ, in consultation with CMS and ECRI, issued a Statement of Work (SOW) contracting ECRI to prepare an evidence report on this topic |
|---|---|
| Item Description: | Title from PDF title page |
| Physical Description: | 1 PDF file (ix, 120) illustrations |